m. kotlyar, c. a. cumbaa, i. jurisica ontario cancer institute, toronto, on [email protected]...
TRANSCRIPT
![Page 1: M. Kotlyar, C. A. Cumbaa, I. Jurisica Ontario Cancer Institute, Toronto, ON juris@ai.utoronto.ca Posters 35 & 10](https://reader035.vdocuments.mx/reader035/viewer/2022070410/56649ed35503460f94be2e45/html5/thumbnails/1.jpg)
M. Kotlyar, C. A. Cumbaa, I. JurisicaOntario Cancer Institute, Toronto, ON
Posters 35 & 10
![Page 2: M. Kotlyar, C. A. Cumbaa, I. Jurisica Ontario Cancer Institute, Toronto, ON juris@ai.utoronto.ca Posters 35 & 10](https://reader035.vdocuments.mx/reader035/viewer/2022070410/56649ed35503460f94be2e45/html5/thumbnails/2.jpg)
Predisposition
DiagnosisPrognosis
Treatment plan
Early markers
![Page 3: M. Kotlyar, C. A. Cumbaa, I. Jurisica Ontario Cancer Institute, Toronto, ON juris@ai.utoronto.ca Posters 35 & 10](https://reader035.vdocuments.mx/reader035/viewer/2022070410/56649ed35503460f94be2e45/html5/thumbnails/3.jpg)
Target List Interpretation/Prioritization
Lau et al., JCO, 2007
![Page 4: M. Kotlyar, C. A. Cumbaa, I. Jurisica Ontario Cancer Institute, Toronto, ON juris@ai.utoronto.ca Posters 35 & 10](https://reader035.vdocuments.mx/reader035/viewer/2022070410/56649ed35503460f94be2e45/html5/thumbnails/4.jpg)
Source Interactions: 234,135Predicted Interactions: 211,604Total Interactions: 439,813
![Page 5: M. Kotlyar, C. A. Cumbaa, I. Jurisica Ontario Cancer Institute, Toronto, ON juris@ai.utoronto.ca Posters 35 & 10](https://reader035.vdocuments.mx/reader035/viewer/2022070410/56649ed35503460f94be2e45/html5/thumbnails/5.jpg)
1,129 probesets associated with survival in lung cancer from 24 studies
Maps to 772 proteins in I2D Network comprises 5,925 proteins; 65,074 interactions
1,129 probesets associated with survival in lung cancer from 24 studies
Maps to 772 proteins in I2D Network comprises 5,925 proteins; 65,074 interactions
![Page 6: M. Kotlyar, C. A. Cumbaa, I. Jurisica Ontario Cancer Institute, Toronto, ON juris@ai.utoronto.ca Posters 35 & 10](https://reader035.vdocuments.mx/reader035/viewer/2022070410/56649ed35503460f94be2e45/html5/thumbnails/6.jpg)
Zhu et al., Clin Lung Cancer, 2009
Network from analyzed signatures
![Page 7: M. Kotlyar, C. A. Cumbaa, I. Jurisica Ontario Cancer Institute, Toronto, ON juris@ai.utoronto.ca Posters 35 & 10](https://reader035.vdocuments.mx/reader035/viewer/2022070410/56649ed35503460f94be2e45/html5/thumbnails/7.jpg)
Combined Signature and NIH Networks
(from Shedden et al., Nat Med, 2008)
![Page 8: M. Kotlyar, C. A. Cumbaa, I. Jurisica Ontario Cancer Institute, Toronto, ON juris@ai.utoronto.ca Posters 35 & 10](https://reader035.vdocuments.mx/reader035/viewer/2022070410/56649ed35503460f94be2e45/html5/thumbnails/8.jpg)
Analyzing “Signatures from Validated Signatures“ (from Lau et al., JCO, 2007)
Boutros et al., PNAS, 2009
8 studies pooled589 patient samples
![Page 9: M. Kotlyar, C. A. Cumbaa, I. Jurisica Ontario Cancer Institute, Toronto, ON juris@ai.utoronto.ca Posters 35 & 10](https://reader035.vdocuments.mx/reader035/viewer/2022070410/56649ed35503460f94be2e45/html5/thumbnails/9.jpg)
Signature Explosion 113 genes in 4 test datasets 10 M 6-gene permutations
16.4% of all 6-gene signatures are significant (P<0.05)3.28-fold greater than expected
by chance
1,789 signatures perform better across all 4 validation datasets
Boutros et al., PNAS, 2009
•
![Page 10: M. Kotlyar, C. A. Cumbaa, I. Jurisica Ontario Cancer Institute, Toronto, ON juris@ai.utoronto.ca Posters 35 & 10](https://reader035.vdocuments.mx/reader035/viewer/2022070410/56649ed35503460f94be2e45/html5/thumbnails/10.jpg)
Solutions?
• Better analysis
–∫(data, methods)
• More protein interactions– ~30% of signature genes
do not have known PPIs
![Page 11: M. Kotlyar, C. A. Cumbaa, I. Jurisica Ontario Cancer Institute, Toronto, ON juris@ai.utoronto.ca Posters 35 & 10](https://reader035.vdocuments.mx/reader035/viewer/2022070410/56649ed35503460f94be2e45/html5/thumbnails/11.jpg)
74,944 x 74,944 predictions 14,889 proteins, 100,083 interactions
16,259 proteins,151,312 interactions
Filter probability >75%
54,150 interactions5,725 proteins
Text Mining:43.2% sensitivity70.2% specificity
Evidence for ~67%New evidence for ~40%Avg. from 1.05 to 9.5
21,543 proteins,265,957 interactions
HumanIntact: 32K (8Kp)MINT: 21K (6.2Kp)HPRD: 38K (8.5Kp)DIP: 2.3K (1.5Kp)
![Page 12: M. Kotlyar, C. A. Cumbaa, I. Jurisica Ontario Cancer Institute, Toronto, ON juris@ai.utoronto.ca Posters 35 & 10](https://reader035.vdocuments.mx/reader035/viewer/2022070410/56649ed35503460f94be2e45/html5/thumbnails/12.jpg)
310 lung, ovarian, prostate and head&neck cancer targets; network with 13,510 proteins and 104,765 interactions
Cancer – PDB – PSI
![Page 13: M. Kotlyar, C. A. Cumbaa, I. Jurisica Ontario Cancer Institute, Toronto, ON juris@ai.utoronto.ca Posters 35 & 10](https://reader035.vdocuments.mx/reader035/viewer/2022070410/56649ed35503460f94be2e45/html5/thumbnails/13.jpg)
![Page 14: M. Kotlyar, C. A. Cumbaa, I. Jurisica Ontario Cancer Institute, Toronto, ON juris@ai.utoronto.ca Posters 35 & 10](https://reader035.vdocuments.mx/reader035/viewer/2022070410/56649ed35503460f94be2e45/html5/thumbnails/14.jpg)
Conclusions Best signatures are not
created from the most differential genes“Sub-signatures” can be
even more accurate “Brute force” can identify
gold standard Integrative analysis and
heuristic approach may:Identify all good signaturesHelp to interpret biology
![Page 15: M. Kotlyar, C. A. Cumbaa, I. Jurisica Ontario Cancer Institute, Toronto, ON juris@ai.utoronto.ca Posters 35 & 10](https://reader035.vdocuments.mx/reader035/viewer/2022070410/56649ed35503460f94be2e45/html5/thumbnails/15.jpg)
Acknowledgment
ophid.utoronto.ca/navigator
ophid.utoronto.ca/i2d
ophid.utoronto.ca/genecards
http://www.conquercancer.ca
http://www.worldcommunitygrid.org
D. Strumpf, P. Boutros, K. Brown, S. Der, W. Xie, D. Otasek, A. MuhammadF. Breard, R. LuY. Niu, K. Fortney, R. Yan, R. Ramnarine, S. Rahmati, E. Shirdel, D. Rosu, A. Ghavidel, J. Geraci, L. Waldron
ophid.utoronto.ca/cdip
M. S. Tsao, F. Shepherd, L. Penn , M. PintilieNIH Director’s Challenge Consortium I. Stagljar, I. DikicD. Wigle, T. Kislinger…
M. McGuffin, B. Devani, I. Van Toch M. Soloviev, S. Grant, J. Jiang,
![Page 16: M. Kotlyar, C. A. Cumbaa, I. Jurisica Ontario Cancer Institute, Toronto, ON juris@ai.utoronto.ca Posters 35 & 10](https://reader035.vdocuments.mx/reader035/viewer/2022070410/56649ed35503460f94be2e45/html5/thumbnails/16.jpg)